118 related articles for article (PubMed ID: 30061262)
1. Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines.
Arakawa K; Hata K; Kawai K; Tanaka T; Nishikawa T; Sasaki K; Shuno Y; Kaneko M; Hiyoshi M; Emoto S; Murono K; Nozawa H
Anticancer Res; 2018 Aug; 38(8):4871-4876. PubMed ID: 30061262
[TBL] [Abstract][Full Text] [Related]
2. Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome.
Serrano M; Lage P; Belga S; Filipe B; Francisco I; Rodrigues P; Fonseca R; Chaves P; Claro I; Albuquerque C; Pereira AD
Fam Cancer; 2012 Dec; 11(4):571-8. PubMed ID: 22776989
[TBL] [Abstract][Full Text] [Related]
3. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
[TBL] [Abstract][Full Text] [Related]
5. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
[TBL] [Abstract][Full Text] [Related]
6. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
[TBL] [Abstract][Full Text] [Related]
7. A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting.
Ramsoekh D; Wagner A; van Leerdam ME; Dinjens WN; Steyerberg EW; Halley DJ; Kuipers EJ; Dooijes D
Gut; 2008 Nov; 57(11):1539-44. PubMed ID: 18625694
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Bethesda guidelines in relation to microsatellite instability.
Wüllenweber HP; Sutter C; Autschbach F; Willeke F; Kienle P; Benner A; Bähring J; Kadmon M; Herfarth C; von Knebel Doeberitz M; Gebert J
Dis Colon Rectum; 2001 Sep; 44(9):1281-9. PubMed ID: 11584201
[TBL] [Abstract][Full Text] [Related]
9. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for Characterizing Microsatellite Instability in Persian Lynch Syndrome Patients.
Farahani N; Nikpou P; Emami MH; Hashemzadeh M; Zeinalian M; Shariatpanahi SS; Salehi R
Asian Pac J Cancer Prev; 2016; 17(9):4259-4265. PubMed ID: 27797228
[TBL] [Abstract][Full Text] [Related]
11. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
[TBL] [Abstract][Full Text] [Related]
12. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.
Jenkins MA; Hayashi S; O'Shea AM; Burgart LJ; Smyrk TC; Shimizu D; Waring PM; Ruszkiewicz AR; Pollett AF; Redston M; Barker MA; Baron JA; Casey GR; Dowty JG; Giles GG; Limburg P; Newcomb P; Young JP; Walsh MD; Thibodeau SN; Lindor NM; Lemarchand L; Gallinger S; Haile RW; Potter JD; Hopper JL; Jass JR;
Gastroenterology; 2007 Jul; 133(1):48-56. PubMed ID: 17631130
[TBL] [Abstract][Full Text] [Related]
13. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.
Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738
[TBL] [Abstract][Full Text] [Related]
15. Validation and simplification of Bethesda guidelines for identifying apparently sporadic forms of colorectal carcinoma with microsatellite instability.
Cravo ML; Fidalgo PO; Lage PA; Albuquerque CM; Chaves PP; Claro I; Gomes T; Gaspar C; Soares JO; Nobre-Leitão C
Cancer; 1999 Feb; 85(4):779-85. PubMed ID: 10091754
[TBL] [Abstract][Full Text] [Related]
16. Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study.
Tranø G; Sjursen W; Wasmuth HH; Hofsli E; Vatten LJ
Br J Cancer; 2010 Feb; 102(3):482-8. PubMed ID: 20051945
[TBL] [Abstract][Full Text] [Related]
17. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
[TBL] [Abstract][Full Text] [Related]
19. Observational Study: Familial Relevance and Oncological Significance of Revised Bethesda Guidelines in Colorectal Patients That Have Undergone Curative Resection.
Jung WB; Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Medicine (Baltimore); 2016 Feb; 95(6):e2723. PubMed ID: 26871811
[TBL] [Abstract][Full Text] [Related]
20. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
